Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_assertion type Assertion NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_head.
- NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_assertion description "[We used six thyroid cancer cell lines: TPC-1 (papillary), FTC-133, FTC-236, FTC-238 (follicular), XTC-1 (H�rthle cell), and ARO (anaplastic).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_provenance.
- NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_assertion evidence source_evidence_literature NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_provenance.
- NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_assertion SIO_000772 12843186 NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_provenance.
- NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_assertion wasDerivedFrom befree-2016 NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_provenance.
- NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_assertion wasGeneratedBy ECO_0000203 NP400652.RAfoq7WxhrUHaJ8v4dj94QmhREapf3kaUII_NqUdUnuJk130_provenance.